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Fifteen years ago, Retrovirology was amongst the first 
open-access journals to be established through Biomed 
Central, instigated by our late Founding Editor Dr. Kuan-
Teh Jeang. Since then, in what seemed like a rather dar-
ing move to be paper-free, Retrovirology has witnessed 
the exponential growth of open access journals that have 
changed the landscape of scientific publishing and com-
munications. As was pointed out by the staff editors in 
PLoS Biology [1], the infancy of open access journal was 
a very different time from our present day, which was 
before smartphones, prior to most of the digital social 
media platforms and at a time when we had only begun 
to learn about the completed DNA sequences from the 
Human Genome Project [1].
Dr. Kuan-Teh Jeang (known universally as Teh) was 
an accomplished virologist and chief of the molecular 
virology section of the Laboratory of Molecular Micro-
biology at the NIAID NIH intramural program. Teh was 
a prolific scientist who authored more than 300 publica-
tions before he left us at the tragically young age of 54. 
Through open access publishing, Teh saw an opportunity 
to create a platform for retrovirologists to publish their 
findings in a timely manner as well as actively dissemi-
nating these publications to the community. Many of us 
vividly remember the enthusiastic emails that Teh sent us 
regarding any news or hot-off the press publications from 
Retrovirology.
From the inaugural digital issue of Retrovirology, 
Teh pledged to serve our community by providing fast, 
fair, and responsive editing to all submissions [2], a 
philosophy that remains as the cornerstone of our prac-
tice in publishing with Retrovirology. Since day one, Teh 
amassed together an impressive team of Founding Asso-
ciate Editors to lead this journal, including Mark Wain-
berg, Andrew Lever, Monsef Benkirane, Ben Berkhout, 
Masahiro Fujii, and Michael Lairmore. Throughout the 
years, a number of well-regarded researchers have also 
joined the team of Associate Editors and Guest Editors 
in Retrovirology, including Robin Weiss, Persephone Bor-
row, Ariberto Fassati, J. Victor Garcia-Martinez, Paul 
Gorry, David Margolis, Monique Nijhuis, Leslie Parent, 
Klaus Strebel, Francois Venter, Frank Kirchhoff, Marit 
van Gils, Alexander Pasternak, and Rogier Sanders.
In 2005, Teh garnered financial support to establish 
the Retrovirology Prize designed, not as a typical award 
for lifetime achievement to the most senior researchers, 
but aimed at mid-career scientists between the ages of 45 
and 60—‘arguably the most productive denizens of sci-
ence’ (as Teh might have put it) [3] or ‘the glum-looking 
bunch of scientists’ traversing their “midlife crises” (as 
Teh would have put it) [3]. Joking aside, the Retrovirol-
ogy Prize has provided us with an opportunity to honour 
some of the amazing scientists who have contributed to 
our community at their ‘mid-career’ stages but who are 
not yet senior enough to receive the awards commonly 
given to reflect the end of a career. As one would expect, 
the Retrovirology Prize has since become a highly sought-
after award within our community, and many legends of 
our time are now part of this unique club of accomplished 
scientists (https ://www.biome dcent ral.com/colle ction s/
retro virol ogy-prize ). The annual deliberation process is 
often fierce but respectful, and the only constant being 
that there are more deserving individuals than the single 
award that we are able to give out each year. In 2005, the 
first recipient of Retrovirology Prize was Professor Ste-
phen Goff at Columbia University [4], and recipients of 
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subsequent Retrovirology Prize winners are listed (https 
://www.biome dcent ral.com/colle ction s/retro virol ogy-
prize ). In recognition of the contribution of Teh to Retro-
virology and to commemorate his untimely departure, the 
Retrovirology Prize was renamed as the Kuan-Teh Jeang 
Retrovirology Prize in 2015.
Throughout its short 15 years of existence, Retrovirol-
ogy has grown from a modest journal that was largely 
driven by Teh, to a point where it is now recognised as 
a highly respected journal within our community. Retro-
virology has witnessed and published a number of man-
uscripts that have had profound impacts on our field. 
While it is impractical to list or to recap all of the land-
mark works that have been published in Retrovirology, we 
have selected a few of our collative personal favourites to 
showcase some of the contributions that our colleagues 
have made through publications in Retrovirology.
Some of the most recognised publications include:
• Gila-Gaur and Strebel’s review on HIV Vif and 
APOBEC proteins [5];
• Descours et  al. research manuscript on SAMHD1 
HIV restriction in quiescent T cells [6];
• Sebastian and Luban’s research report on Trim5a 
restricts retrovirus via capsid domain [7];
• Weiss’s review on endogenous retroviruses [8];
• Towers’s review on tripartite motif proteins and 
cyclophilin A [9].
Other timely manuscripts include:
• Work dissecting the relationship between HIV tran-
scription and latency by van Lint et al. [10];
• The series of manuscripts that helped to show that 
xenotropic murine leukemia virus related virus 
(XMRV) is not a human pathogen [11–23];
• An early study that helped set the tone of using 
humanised mice to study HIV infection and patho-
genesis in vivo by Berges et al. [24]; and
• The potential roles of microRNA in retrovirus related 
diseases [25–28].
Other publication highlights can also be found in the 
following weblinks (incorporating all of the papers that 
team of AEs suggest).
Retrovirology has done many things like this well, but 
there are still many areas for us to improve on including 
widening the diversity of our publications. Tradition-
ally, Retrovirology was set up as a journal with a strong 
molecular virology focus, and we have not published a 
significant number of manuscripts that have immunolog-
ical-, clinical or structural biological themes. As we look 
toward our future, Retrovirology will actively support 
manuscripts in these areas of retrovirus research that 
have not been well represented in our publication history.
We also plan to increase diversity in our editorial 
board, authors and readers. In an attempt to better reflect 
the diversity of the retrovirus community, our current 
editorial board comprises researchers from most of the 
retrovirus research-intensive countries. As we don’t yet 
fully accurately reflect our community this is our aspira-
tion and with the ongoing support from our submitting 
authors and readers, we are determined to make Retrovi-
rology the journal that reflects the breadth of our collec-
tive values and commitment to our field.
With the sudden passing of Teh in 2013, Profes-
sors Mark Wainberg and Andrew Lever agreed to take 
on the roles of Co-Editor-in-Chief to lead our journal. 
Approaching the end of a 5  year term as Co-Editor-in-
Chief for Retrovirology, Mark Wainberg sadly left us in an 
untimely manner in 2017 [29]. Mark had authored over 
550 publication spanning his 30  years of work in retro-
viruses [29]. Andrew stepped down this year, becoming 
our first Editor emeritus. Retrovirology has survived all 
these ups and downs and with the support of the retro-
viral community we are beginning to see the metrics rise 
again.
With Andrew’s retirement as Co-Editor-in-Chief from 
Retrovirology, we are delighted to have one of our origi-
nal commissioned meeting reviewers in 2004 [30], Pro-
fessor Susan Ross, takes the helm as Co-Editor-in-Chief 
with Johnson Mak to serve our research community. 
We have also added 4 social media editors (Felipe Diaz-
Griffero, Robert Gifford, Sallie Permar, and Kei Sato) to 
the board, who will be publicizing findings of interest to 
the Retrovirology community.
We have also been proud to support the bi-annual 
Frontiers in Retrovirology Conference, which has 
brought together scientists from all over the world to dis-
cuss state-of-the-art findings in the field. The upcoming 
Fall 2020 conference in Prague (to be organized and led 
by Jiri Hejnar) promises to continue the tradition of out-
standing scientific exchange in the field.
In ancient Greece at around 500 B.C., Heraclitus of 
Ephesus coined the phrase ‘Change is the only constant’, 
Retrovirology is no exception to this rule. To remain rel-
evant and important to our loyal scientific contributors 
the journal must evolve and adapt so that it continues 
to provide a unique specialist forum for this fascinating 
branch of science and medicine.
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